Analyzing the Global Diabetes MarketAruvian's R'searchFebruary 1, 2012 205 Pages - SKU: ARVN6801012 |
|
Global Medication Management System Market 2012-2016
5/3/2013 | published by: Infiniti Research Limited
Global Medication Management System Market 2012-2016 TechNavio's analysts forecast the Global Medication Management System market to grow at a CAGR of 5.42 percent over the period 2012-2016. One of the key factors contributing to this market
|
read more...
|
$2,000.00
|
|
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI
|
read more...
|
$1,175.00
|
|
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers
|
read more...
|
$1,175.00
|
|
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently
|
read more...
|
$1,175.00
|
|
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn
|
read more...
|
$1,175.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should
|
read more...
|
$1,175.00
|
|
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
Russian Pharma Industry In Details
Purpose of this report was to analyze Russian of pharma.
Please pay attention:
Benefits of buying the report:
The report included large volume
|
read more...
|
$3,750.00
|
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, Côte d'Ivoire posts a better performance, but there
|
read more...
|
$1,295.00
|
|
Chile Pharmaceuticals and Healthcare Report Q2 2013
5/1/2013 | published by: Business Monitor International
BMI View: Chile's improving regulation system should bring high quality medicines to the local marketand eventually reduce the country's medical spending. The tightened bioequivalent regulations will boostgenuine medicine sales and force similares out of the
|
read more...
|
$1,175.00
|
|
Croatia Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
Executive Summary BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to bring about an influx of EU funding in modernising thecountry's
|
read more...
|
$1,295.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Prescription Drugs Reports